Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus

Virology

Volumn 256, Issue 1, 1999, Pages 8-14

  Anderson, Sylvia L ^a   Carton, Jill M ^a   Lou, Jing ^a   Xing, Lily ^a   Rubin, Berish Y ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; COMPLEMENTARY RNA; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENCEPHALOMYOCARDITIS VIRUS; EXPRESSION VECTOR; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS;

EID: 0033616531     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9614     Document Type: Article

References (37)

1. Chebath J., Benech P., Revel M., Vigneron M. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature. 330:1987;587-588.
2. Cheng Y. S., Colonno R. J., Yin F. H. Interferon induction of fibroblast proteins with guanylate binding activity. J. Biol. Chem. 258:1983;7746-7750.
3. Cheng Y. S., Patterson C. E., Staeheli P. Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol. Cell. Biol. 11:1991;4717-4725.
4. Coccia E. M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E., Battistini A., Fiorucci G., Orsatti R., Rossi G. B., Chebath J. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology. 179:1990;228-233.
5. Dever T. E., Glynias M. J., Merrick W. C. GTP-binding domain: Three consensus sequence elements with distinct spacing. Proc. Natl. Acad. Sci. USA. 4:1987;1814-1818.
6. Dever T. E., Merrick W. C. The Guanine-Nucleotide Binding Proteins. 1989;Plenum, New York.
7. Frese M., Kochs G., Meier-Dieter U., Siebler J., Haller O. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69:1995;3904-3909.
8. Friedman R. M., Sonnabend J. A. Inhibition of interferon action by puromycin. J. Immunol. 95:1965;696-703.
9. Haller O., Frese M., Rost D., Nuttall P. A., Kochs G. Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 69:1995;2596-2601.
10. Johnson H. M. Pfeffer L. M. Mechanisms of Interferon Actions. 1987;CRC Press, Boca Raton.
11. r. EMBO J. 6:1987;689-697.
12. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T. W., Taniguchi T. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
13. Kitajewski J., Schneider R. J., Safer B., Munemitsu S. M., Samuel C. E., Thimmappaya B., Shenk T. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell. 45:1986;195-200.
14. Kumar R., Tiwari R. K., Kusari J., Sen G. C. Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons. J. Virol. 61:1987;2727-2732.
15. Lengyel P. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51:1982;251-282.
16. Lockart R. Z. Jr. The necessity of cellular RNA and protein synthesis for viral inhibition from interferon. Biochem. Biophys. Res. Commun. 15:1964;513-518.
17. Margolis-Nunno H., Rubin B. Y., Anderson S. L., Lunn R. M., Roy S. N., Dizik M., Sen G. C. Isolation of cDNA clones for the interferon-induced 67,000-dalton protein: Direct induction of a family of mRNAs by human interferon-alpha and interferon-gamma. J. Interferon Res. 10:1990;309-319.
18. Meurs E. F., Watanabe Y., Kadereit S., Barber G. N., Katze M. G., Chong K., Williams B. R., Hovanessian A. G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66:1992;5804-5814.
19. Neun R., Richter M. F., Staeheli P., Schwemmle M. GTPase properties of the interferon-induced human guanylate-binding protein 2. FEBS Lett. 390:1996;69-72.
20. Pavlovic J., Zurcher T., Haller O., Staeheli P. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:1990;3370-3375.
21. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Annu. Rev. Biochem. 56:1987;727-777.
22. Pine R. Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J. Virol. 66:1992;4470-4478.
23. Reis L. F., Harada H., Wolchok J. D., Taniguchi T., Vilcek J. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J. 11:1992;185-193.
24. Rubin B. Y., Gupta S. L. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc. Natl. Acad. Sci. USA. 77:1980;5928-5932.
25. Rubin B. Y., Anderson S. L., Lunn R. M., Hellermann G. R., Richardson N. K., Smith L. J. Production of a monoclonal antibody directed against an interferon-induced 56,000-dalton protein and its use in the study of this protein. J. Virol. 62:1988a;1875-1880.
26. Rubin B. Y., Anderson S. L., Lunn R. M., Richardson N. K., Hellermann G. R., Smith L. J., Old L. J. Tumor necrosis factor and IFN induce a common set of proteins. J. Immunol. 141:1988b;1180-1184.
27. Schneider R. J., Safer B., Munemitsu S. M., Samuel C. E., Shenk T. Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc. Natl. Acad. Sci. USA. 82:1985;4321-4325.
28. Schnorr J. J., Schneider-Schaulies S., Simon-Jodicke A., Pavlovic J., Horisberger M. A., ter Meulen V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:1993;4760-4768.
29. Schwemmle M., Staeheli P. The interferon-induced 67-kDa guanylate-binding protein (hGBP1) is a GTPase that converts GTP to GMP. J. Biol. Chem. 269:1994;11299-11305.
30. Sen G. C., Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267:1992;5017-5020.
31. Staeheli P. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38:1990;147-200.
32. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell. 44:1986;147-158.
33. Taylor J. Inhibition of interferon action by actinomycin. Biochem. Biophys. Res. Commun. 14:1964;447-451.
34. Thimme R., Frese M., Kochs G., Haller O. Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Virology. 211:1995;296-301.
35. Wynn T. A., Nicolet C. M., Paulnock D. M. Identification and characterization of a new gene family induced during macrophage activation. J. Immunol. 147:1991;4384-4392.
36. Yang Y. L., Reis L. F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B. R., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:1995;6095-6106.
37. Zurcher T., Pavlovic J., Staeheli P. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology. 187:1992;796-800.